Stay updated with breaking news from Oncological Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists from Mount Sinai have recently found potentially serious side effects related to a new form of immunotherapy known as CAR-T cell therapy, which was recently approved for the treatment of multiple myeloma.
_on_a_T-cell_is_binding_to_a_molecule_on_a_cancer_-_Alpha_Tauri_3D_Graphics_M1_dc8762afeaee4937ad644739f274c7a5-620x480.jpg)
Mount Sinai scientists have become the first to report a potentially serious side effect related to a new form of immunotherapy known as CAR-T cell therapy, which was recently approved for the treatment of multiple myeloma.
New York, NY (PRWEB) November 30, 2021 -- The National Cancer Institute has awarded Mount Sinai researchers $3.15 million in grant funding to assess the
New York, NY (PRWEB) October 19, 2021 -- Patients with the blood cancer multiple myeloma often mount a poor antibody response to COVID-19 vaccines. Mount
The findings of a new study by Mount Sinai and UC San Diego researchers, for the first time, have shown how mutations affecting a cellular process called RNA sp